These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 21784388
21. Guidewire-induced coronary artery perforation and tamponade during PCI: in-hospital outcomes and impact on long-term survival. Stathopoulos I, Panagopoulos G, Kossidas K, Jimenez M, Garratt K. J Invasive Cardiol; 2014 Aug; 26(8):371-6. PubMed ID: 25091096 [Abstract] [Full Text] [Related]
22. Bivalirudin during primary PCI in acute myocardial infarction. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R, HORIZONS-AMI Trial Investigators. N Engl J Med; 2008 May 22; 358(21):2218-30. PubMed ID: 18499566 [Abstract] [Full Text] [Related]
23. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study. Cortese B, Micheli A, Picchi A, Bandinelli L, Brizi MG, Severi S, Limbruno U. Coron Artery Dis; 2009 Aug 22; 20(5):348-53. PubMed ID: 19543084 [Abstract] [Full Text] [Related]
24. Effectiveness and safety of bivalirudin during percutaneous coronary intervention in a single medical center. Gurm HS, Rajagopal V, Fathi R, Vivekanathan D, Yadav JS, Bhatt DL, Ellis SG, Lincoff AM, Topol EJ. Am J Cardiol; 2005 Mar 15; 95(6):716-21. PubMed ID: 15757596 [Abstract] [Full Text] [Related]
29. Safety and feasibility of intra-arterial bivalirudin bolus administration during primary angioplasty. Chorzempa A, Tamis J, Simon C, Palazzo A, Leber R, Coven D, Hong MK. Coron Artery Dis; 2013 Aug 15; 24(5):419-21. PubMed ID: 23835668 [Abstract] [Full Text] [Related]
30. Comparison of prolonged bivalirudin infusion versus intraprocedural in preventing myocardial damage after percutaneous coronary intervention in patients with angina pectoris. Cortese B, Picchi A, Micheli A, Ebert AG, Parri F, Severi S, Limbruno U. Am J Cardiol; 2009 Oct 15; 104(8):1063-8. PubMed ID: 19801025 [Abstract] [Full Text] [Related]
32. Unfractionated heparin administration in patients treated with bivalirudin during primary percutaneous coronary intervention is associated lower mortality and target lesion thrombosis: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Koutouzis M, Lagerqvist B, James S, Omerovic E, Matejka G, Grip L, Albertsson P. Heart; 2011 Sep 15; 97(18):1484-8. PubMed ID: 21487123 [Abstract] [Full Text] [Related]
33. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy. Sibbing D, Bernlochner I, Schulz S, Massberg S, Schömig A, Mehilli J, Kastrati A. J Am Coll Cardiol; 2012 Jul 31; 60(5):369-77. PubMed ID: 22682553 [Abstract] [Full Text] [Related]
34. Safety and tolerability of high-intensity anticoagulation with bivalirudin during neuroendovascular procedures. Hassan AE, Memon MZ, Georgiadis AL, Vazquez G, Suri MF, Qureshi AI. Neurocrit Care; 2011 Aug 31; 15(1):96-100. PubMed ID: 20721698 [Abstract] [Full Text] [Related]
35. Prehospital treatment of patients with acute myocardial infarction with bivalirudin. Hirschl MM, Mayr H, Erhart F, Brunner W, Steger F, Gattermeier M, Pfeffel F. Am J Emerg Med; 2012 Jan 31; 30(1):12-7. PubMed ID: 20971597 [Abstract] [Full Text] [Related]
36. Efficacy and safety of bivalirudin in patients with diabetes mellitus undergoing percutaneous coronary intervention in current clinical practice. Kim LK, Wong SC, Minutello RM, Bergman G, Feldman DN. J Invasive Cardiol; 2010 Mar 31; 22(3):94-100. PubMed ID: 20197573 [Abstract] [Full Text] [Related]
38. Bleeding risk and outcomes of Bivalirudin versus Glycoprotein IIb/IIIa inhibitors with targeted low-dose unfractionated Heparin in patients having percutaneous coronary intervention for either stable or unstable angina pectoris. Steinberg DH, Shah P, Kinnaird T, Pinto Slottow TL, Roy PK, Okabe T, Bonello L, de Labriolle A, Smith KA, Torguson R, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Lindsay J, Waksman R. Am J Cardiol; 2008 Jul 15; 102(2):160-4. PubMed ID: 18602514 [Abstract] [Full Text] [Related]